NORCROSS, GA, June 03, 2013 (Press-News.org) The Atlanta video production firm, Optimum Productions, wants to remind business owners of the benefits of video advertising. Television and Internet videos are the best ways to consistently attract new clients; they are a cost-effective alternative to traditional print methods such as using a billboard. They have proven to be particularly useful for companies who have an online presence.
The Atlanta video business notes that the return on investment (ROI) is just one reason why using video is the way to go these days. They also point out that more people have become immersed in the field of technology, which means relying on print sources for marketing efforts is not only outdated, but also financially disastrous in the long run.
According to Danny Gonzales, Owner of Optimum Productions, "Video is dynamic and hip. It is much easier to engage customers with an interactive clip than trying to sell them with a sign or other print source. Video is also mobile, meaning it can be accessed anywhere. It is bound by little to no limitations, which makes its potential all the more powerful for business owners."
Video is Everywhere, Notes the Atlanta Video Firm
The Atlanta video production firm explains that mobile phone usage has skyrocketed in the last couple of years and the trend shows no sign of slowing down. Optimum Productions encourages all companies to break away from their traditional marketing methods if they want to experience true profit. To maximize the effects of your advertising, the Atlanta video business also notes that having embedded videos directly on your company website is guaranteed to attract more customers.
Optimum Productions provides a large variety of services for Atlanta corporate videos. To learn more about how they can help you, please visit http://www.optimumproductions.com.
About Optimum Productions:
Optimum Productions is your resource for video production in Atlanta. Our video production staff is comprised of creative innovators dedicated to superior video production. Since 2007, we have been creating compelling content for a long list of discerning clients. We offer the tools, skills, and talent that are essential to the highest level of video production.
Learn more by visiting http://www.optimumproductions.com.
For all media inquiries, please contact:
Allie Petit
Content Manager
Cardinal Web Solutions
http://www.CardinalWebSolutions.com
Atlanta Video Pros, Optimum Productions, Suggest Connecting with Customers via Interactive Videos
The Atlanta video experts, Optimum Productions, would like to remind business owners that using videos to promote products and services is a great way to bring in customers. Video advertising has proven to be highly effective.
2013-06-03
ELSE PRESS RELEASES FROM THIS DATE:
Silver & Black Series Alumni Expected to Make a Presence at MLB's First-Year Player Draft as 2014s and 2015s Showcase their Talent Live June 9th & 10th
2013-06-03
The 10th annual Silver & Black Series presented by the Chicago Scouts Association will take off on June 9th at Symonds/Puckett Field, Triton College in River Grove, Illinois. This year the underclassmen (2015s) will workout first on Sunday with the 2014 graduates taking the field on Monday. In September, Hampshire High School will host the Silver & Black Series with the 2016s working out on September 15th and the 2017s on September 22nd.
Player registration begins on Sunday, June 9 and Monday, June 10 at 8 AM with an expected first pitch beginning at 10 AM. ...
"Worst Ever" Slam by Yahoo! Boosts Sales of New ThiPad Tablet Stand
2013-06-03
In their May 17th "Digital Crave" shopping blog, Yahoo! included the new ThiPad thigh-mounted tablet stand in a piece titled "The Worst iPad Accessories--Ever."
"And they did us a favor," says Jerry McTigue, creator of the ThiPad. "Because the hundreds of readers who went to the ThiPad.com website to see just how bad a product it was, actually discovered how good it was. And they started buying it."
McTigue believes that if the ThiPad can gain converts with horrible publicity like that, there's no telling what it would do if ...
Some patients with treatment-resistant colorectal cancers may have a new option
2013-06-02
PHILADELPHIA — A subset of colorectal cancers responds to anti-epidermal growth factor receptor (anti-EGFR) therapies, but develops resistance within months. Among cancers that develop resistance to anti-EGFR therapy, some showed overexpression of a gene called MET, according to a study published in the June issue of Cancer Discovery, a journal of the American Association for Cancer Research. Preliminary data published in this study showed human tumors with MET amplification, grown in mice, responded to MET inhibitor drugs.
The MET gene is known to be amplified in about ...
Addition of bevacizumab to initial treatment for brain tumors does not extend patients' lives
2013-06-02
Results of a randomized phase III clinical trial conducted by the Radiation Therapy Oncology Group (RTOG) determined that adding bevacizumab to initial treatment for glioblastoma (GBM) did not improve patient overall survival or progression-free survival,. Results were reported June 2 during the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting.
Chicago, Illinois—GBM is the most common primary malignant brain tumor in adults and, despite treatment advances in recent years, the average survival of patients enrolled in clinical trials is ...
New cancer drug shows promise for treating advanced melanoma
2013-06-02
Researchers from UCLA's Jonsson Comprehensive Cancer Center report that a new drug in preliminary tests has shown promising results with very manageable side effects for treating patients with melanoma, the deadliest form of skin cancer.
The results were presented at the 2013 meeting of the American Society of Clinical Oncology today in Chicago by Dr. Antoni Ribas, professor of medicine in the UCLA division of hematology-oncology, who led the research. Following Ribas' presentation, the study was published online ahead of press in the New England Journal of Medicine. ...
Test helps target glioblastoma patients most likely to benefit from bevacizumab
2013-06-02
CHICAGO, IL – A new test may help identify newly diagnosed glioblastoma patients more likely to benefit from bevacizumab (Avastin®), according to new research from The University of Texas MD Anderson Cancer Center.
The results of the study were presented today at the annual meeting of the American Society of Clinical Oncology.
This study is associated with RTOG 0825, a large multi-center Phase III trial that evaluated the addition of bevacizumab to standard chemoradiation and maintenance temozolomide in treating newly diagnosed glioblastoma. Half of the participants ...
Combination of drugs produces dramatic tumor responses in advanced melanoma patients
2013-06-02
CHICAGO, JUNE 2, 2013 — The combination of the immunotherapy drug ipilimumab and the investigational antibody drug nivolumab led to long-lasting tumor shrinkage in more than half of patients with metastatic melanoma, according to results from a Phase I trial simultaneously published online on Sunday, June 2, in The New England Journal of Medicine and presented by Memorial Sloan-Kettering Cancer Center researchers at the 49th Annual Meeting of the American Society of Clinical Oncology (ASCO).
Several patients experienced tumor shrinkage of more than 80 percent within ...
Bevacizumab offers no benefit for newly diagnosed glioblastoma, M.D. Anderson-led study finds
2013-06-02
Chicago, IL – The angiogenesis inhibitor bevacizumab (Avastin) failed to increase overall survival (OS) or statistically significant progression-free survival (PFS) for glioblastoma patients in the frontline setting, according to research led by researchers at The University of Texas MD Anderson Cancer Center.
The study was presented today on the plenary session of the American Society of Clinical Oncology 2013 Annual Meeting by Mark Gilbert, M.D., professor in MD Anderson's Department of Neuro-Oncology.
Glioblastoma is both the most common and lethal form of brain ...
US oncologists report high career satisfaction, yet many suffer symptoms of burnout
2013-06-02
CHICAGO -- Even though a majority of U.S. oncologists report satisfaction with their careers, many say they have experienced at least one symptom of burnout, a Mayo Clinic-led study has found. The study was released during the American Society of Clinical Oncology's annual meeting in Chicago.
"Oncology can be a tremendously rewarding area of medicine, but caring for patients with cancer is also demanding and stressful," says lead author Tait Shanafelt, M.D., a Mayo Clinic hematologist/oncologist. "Oncologists work long hours, supervise the administration of highly toxic ...
Abnormalities in HER2 gene found in wide variety of advanced cancers
2013-06-02
(CHICAGO) The HER2 growth-factor gene is known to be over-active in breast and gastro-esophageal cancers. But now, irregularities in the genes 's expression — among them mutations, amplifications, substitutions, and translocations — have been found in 14 different advanced solid tumors.
The results of the study of more than 2,000 tumors, being presented at the annual meeting of the American Society of Clinical Oncology (ASCO), both surprised researchers and provided hope that some of these tumors might benefit from the three anti-HER2 therapies now in clinical use.
"No ...
LAST 30 PRESS RELEASES:
New study shows how the spleen helps the immune system accept a transplant
New Mayo Clinic study advances personalized prostate cancer education with an EHR-integrated AI agent
Researchers identify novel therapeutic target to improve recovery after nerve injury
Microbes in breast milk help populate infant gut microbiomes
Reprogramming immunity to rewrite the story of Type 1 diabetes
New tool narrows the search for ideal material structures
Artificial saliva containing sugarcane protein helps protect the teeth of patients with head and neck cancer
Understanding the role of linear ubiquitination in T-tubule biogenesis
Researchers identify urban atmosphere as primary reservoir of microplastics
World’s oldest arrow poison – 60,000-year-old traces reveal early advanced hunting techniques
Bristol scientists discover early sponges were soft
New study uncovers how rice viruses manipulate plant defenses to protect insect vectors
NSF–DOE Vera C. Rubin Observatory spots record-breaking asteroid in pre-survey observations
Ribosomal engineering creates “super-probiotic” bacteria
This self-powered eye tracker harnesses energy from blinking and is as comfortable as everyday glasses
Adverse prenatal exposures linked to higher rates of mental health issues, brain changes in adolescents
Restoring mitochondria shows promise for treating chronic nerve pain
Nature study identifies a molecular switch that controls transitions between single-celled and multicellular forms
USU chemists' CRISPR discovery could lead to single diagnostic test for COVID, flu, RSV
Early hominins from Morocco reveal an African lineage near the root of Homo sapiens
Small chimps, big risks: What chimps show us about our own behavior
We finally know how the most common types of planets are created
Thirty-year risk of cardiovascular disease among healthy women according to clinical thresholds of lipoprotein(a)
Yoga for opioid withdrawal and autonomic regulation
Gene therapy ‘switch’ may offer non-addictive pain relief
Study shows your genes determine how fast your DNA mutates with age
Common brain parasite can infect your immune cells. Here's why that's probably OK
International experts connect infections and aging through cellular senescence
An AI–DFT integrated framework accelerates materials discovery and design
Twist to reshape, shift to transform: Bilayer structure enables multifunctional imaging
[Press-News.org] Atlanta Video Pros, Optimum Productions, Suggest Connecting with Customers via Interactive VideosThe Atlanta video experts, Optimum Productions, would like to remind business owners that using videos to promote products and services is a great way to bring in customers. Video advertising has proven to be highly effective.

